According to recent research, Edinburgh University could be the first in the UK to create a policy helping to make medicine, including diabetes drugs, cheaper for people in the developing world.
The researchers say that they will no longer licence research to pharmaceutical companies unless they are making life-saving medication available to poverty-stricken countries at cost price.
As many as ten million children die each year due to not being able to access affordable drugs, often due to cost alone. Edinburgh University Professor David Webb, from the School of Clinical Sciences and Community Health, reportedly commented:

“Of the challenges facing the world at present, global health and access to medicines is among the most crucial. We hope that by making our medicines as accessible as possible, we will make a real difference to the millions at risk from often preventable diseases .”

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Twice daily dairy intakes could reduce type 2 diabetes risk

Eating cheese, yoghurt or eggs twice a day could help lower the…

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…